Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2026-05-07 @ 5:57 PM
Study NCT ID:
NCT03098160
Status:
UNKNOWN
Last Update Posted:
2017-10-30
First Post:
2017-03-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immunotherapy Study of Evofosfamide in Combination With Ipilimumab
Sponsor:
Threshold Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TH-CR-417
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |